What is the diabetes stem cell treatment in India?

Stem cell therapy is evolving as an advanced therapeutic landscape in diabetes treatment in India. Stem cells derived from umbilical cord tissue or blood, adipose tissue, or bone marrow are multilineage. These cells can differentiate into distinct cell types based on specific stimulation. Researchers have widely explored the regenerative approach for the regeneration of the pancreatic beta islet cells responsible for insulin production. Mesenchymal stem cells (MSCs) are widely used for stem cell treatment in diabetes management. The additional effects include supporting cellular communication, reducing inflammation, promoting repair mechanisms, immunomodulation, creating stronger signalling networks, and establishing a supportive environment.  

In conventional diabetes management, the focus remains on controlling the blood sugar level. The common approach is medication, insulin therapy, dietary management, and physical activities. While stem cell therapy for diabetes in India is integrated as a supportive treatment. They decrease insulin dependency and dependency on the medication. 

In type 1 diabetes, the immune system mistakenly attacks the insulin-producing beta cells in the pancreas. Stem cell therapy focuses on immunomodulation and supporting survival of remaining healthy cells. In type 2 diabetes, the focus is slightly different. Scientists are exploring whether stem cells can help improve insulin response in the body and support repair processes in damaged tissues.

It is important to understand that the area of stem cell therapy for diabetes is still evolving. Thus, it cannot be considered standard therapy for a cure. In the future, large-scale clinical trials must be launched to ensure long-term safety, efficacy, and tolerance of the therapy among all aged patients.